AVTR News and Press, Avantor Inc. From 01/03/23

Avantor® to Participate in the 41st Annual J.P. Morgan Healthcare Conference PR Newswire RADNOR, Pa. , Jan. 3, 2023 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life scien...

Summary Halvorsen's 13F portfolio value decreased marginally from $21.86B to $21.66B this quarter. The number of positions increased from 82 to 88. Viking Global increased Elevance Health, Visa, and McKesson while decreasing T-Mobile US, Parker Hannifin, and Fortive. They also dropped A...

Avantor® to Participate in the 5th Annual Evercore ISI HealthCONx Conference PR Newswire RADNOR, Pa. , Nov. 15, 2022 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the l...

Summary Avantor, Inc. has re-rated heavily to the downside amid a vigorous selloff throughout FY22. Shares now have drifted past 2-year lows and more downside could arrive before Avantor finds a bottom. Fundamental momentum is still strong, with high FCF, ROIC and EPS upside e...

Avantor® Continues Investment to Support Biopharma Market with Opening of New Distribution Center in Dublin, Ireland PR Newswire DUBLIN , Nov. 3, 2022 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products ...

Summary Global growth stocks held up better than value, snapping a two-quarter losing streak, as global recession fears weighed more heavily on companies tied to the broader economy. The Strategy outperformed for the second quarter in a row, thanks in large part to positioning adj...

Summary Having suffered through a sharp decline in earnings multiples, SMID cap growth stocks held up well in a volatile quarter marked by a sharp upward ratcheting of interest rates. The Strategy underperformed its benchmark, primarily due to weakness among health care holdings t...

Summary Equities continued their slide during the third quarter, as investors grew increasingly anxious over the combination of aggressive interest rate increases and a growing likelihood of recession. Health care proved an impediment to relative performance, as the evaporation of...

Avantor, Inc. (AVTR) Q3 2022 Results Earnings Conference Call October 28, 2022, 08:00 AM ET Company Participants Christina Jones - Vice President of Investor Relations Michael Stubblefield - President and Chief Executive Officer Thomas Szlosek - Executive Vice Pr...

Avantor, Inc. ( NYSE: AVTR ) shed ~11% on Friday morning after the life sciences company lowered its full-year guidance despite recording better-than-expected financials for Q3 2022. The company's net sales exceeded previous projections to reach $1.9B with ~1% YoY growth...